Davis's Drug Guide
teplizumab
General
Pronunciation:
tep-liz-ue-mab
Trade Name(s)
- Tzield
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Teplizumab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/5/teplizumab.
Vallerand AHA, Sanoski CAC, . Teplizumab. Davis's Drug Guide. F.A. Davis Company; 2025. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/5/teplizumab. Accessed April 17, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Teplizumab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/5/teplizumab
Vallerand AHA, Sanoski CAC, . Teplizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 17]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/5/teplizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - teplizumab
ID - 3580097
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580097/5/teplizumab
PB - F.A. Davis Company
ET - 19
DB - Emergency Central
DP - Unbound Medicine
ER -
